WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS)
$6.01 -0.215 (-3.4538%)
Analysed WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) News Sources
WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic
13-01-2026
yahoo.com
Vertex Partners With WuXi To Broaden Autoimmune Pipeline Beyond Cystic Fibrosis
10-02-2026
yahoo.com
Vertex Autoimmune Deal With WuXi Adds New Angle To VRTX Valuation Story
15-02-2026
yahoo.com
WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO
18-08-2026
yahoo.com
WuXi Biologics Reports Strong Profitable Growth in H1 2026
25-08-2026
yahoo.com
Big Pharma Is Pouring Billions Into China’s Biotechs
14-09-2026
yahoo.com
WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership
16-09-2026
yahoo.com
What is the current price of WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS)?
The current price of WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) is $6.01.
WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) since the previous trading day is $-0.215.
WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) since the previous trading day is -3.4538%.
What is the most recent average sentiment score for WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS)?
The most recent average sentiment score for WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) is 69 out of 100.
What is the most recent average sentiment for WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS)?
The most recent sentiment for WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS) is .
SEC-8K** Filing Available For WUXI BIOLOGICS CAYMAN INC (WXIBF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.